TipRanks
Go Ultimate55% OFF

Alnylam Pharma (DUL) Balance Sheet

Alnylam Pharma Balance Sheet

Alnylam Pharma's total assets for Q3 2026 were $7.99B, an increase of 43.82% from the previous quarter. DE:DUL total liabilities were $4.39B for the fiscal quarter, a 4.43% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 4.97B$ 4.24B$ 3.83B$ 3.55B$ 3.64B
$ 4.18B$ 4.17B$ 4.05B$ 3.70B$ 3.06B
$ 789.18M$ 67.09M$ -220.64M$ -158.22M$ 588.20M

Currency in USD

Alnylam Pharma Debt to Assets

02B4B6B0 %40 %80 %120 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets